Literature DB >> 5116211

Hydrogen peroxide utilization in myeloperoxidase-deficient leukocytes: a possible microbicidal control mechanism.

S J Klebanoff, S H Pincus.   

Abstract

Phagocytosis-induced formate and glucose C-1 oxidation by the polymorphonuclear leukocytes of a patient with hereditary myeloperoxidase deficiency was considerably greater than normal. The addition of catalase to the leukocyte suspension was required for optimum formate oxidation. Azide and cyanide increased glucose C-1 oxidation by normal leukocytes but had little or no effect on myeloperoxidase-deficient leukocytes suggesting that these agents normally stimulate glucose C-1 oxidation, in part, by inhibition of myeloperoxidase. It is suggested that the inhibition or absence of myeloperoxidase results in an increased utilization of H(2)O(2) in nonmyeloperoxidase-mediated H(2)O(2)-dependent reactions such as formate oxidation and hexose monophosphate pathway activation. The possibility of a microbicidal control mechanism in which a decrease in the microbicidal activity of myeloperoxidase is offset, in part, by an increase in the nonenzymatic microbicidal activity of H(2)O(2) is considered.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5116211      PMCID: PMC292158          DOI: 10.1172/JCI106718

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Improvement of leukocyte bactericidal activity in chronic granulomatous disease.

Authors:  R B Johnston; R L Baehner
Journal:  Blood       Date:  1970-03       Impact factor: 22.113

2.  Iodination defect in the leukocytes of a patient with chronic granulomatous disease of childhood.

Authors:  S J Klebanoff; L R White
Journal:  N Engl J Med       Date:  1969-02-27       Impact factor: 91.245

3.  The H2O2-production by polymorphonuclear leukocytes during phagocytosis.

Authors:  M Zatti; F Rossi; P Patriarca
Journal:  Experientia       Date:  1968-07-15

4.  Glutathione and the hexose monophosphate shunt in phagocytizing and hydrogen peroxide-treated rat leukocytes.

Authors:  P W Reed
Journal:  J Biol Chem       Date:  1969-05-10       Impact factor: 5.157

5.  Quantitative leukocyte iodination.

Authors:  S H Pincus; S J Klebanoff
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

6.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

7.  Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing.

Authors:  G L Mandell; E W Hook
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

8.  Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan; M L Karnovsky
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

9.  Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes.

Authors:  S J Klebanoff
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

10.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more
  38 in total

1.  Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms.

Authors:  W D Biggar; S Buron; B Holmes
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

2.  Enhancement of granulocyte chemiluminescence with hydroxyl radical scavengers.

Authors:  L Harvath
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Neutrophil-mediated cytotoxicity triggered by immune complexes: the role of reactive oxygen metabolites.

Authors:  J R Geffner; M Giordano; M S Palermo; A Prat; G P Serebrinsky; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

4.  Differences in oxygen metabolism of phagocytosing monocytes and neutrophils.

Authors:  M Reiss; D Roos
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

5.  Effects of cigarette smoke components on in vitro chemotaxis of human polymorphonuclear leukocytes.

Authors:  R B Bridges; J H Kraal; L J Huang; M B Chancellor
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

6.  Studies on the mechanism of metabolic stimulation in polymorphonuclear leukocytes during phagocytosis. Activators and inhibitors of the granule bound NADPH oxidase.

Authors:  P Patriarca; P Dri; K Kakinuma; F Rossi
Journal:  Mol Cell Biochem       Date:  1976-09-30       Impact factor: 3.396

7.  Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.

Authors:  L Harvath; H J Amirault; B R Andersen
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  Ethylene formation by polymorphonuclear leukocytes. Role of myeloperoxidase.

Authors:  S J Klebanoff; H Rosen
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Mechanisms of methylene blue stimulation of the hexose monophosphate shunt in erythrocytes.

Authors:  E N Metz; P Balcerzak; A L Sagone
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

Review 10.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.